Infusion Pump Systems and Methods
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 12/195,034, filed Aug 20, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,221,385 | Infusion Pump Systems and Methods In force · High confidence UsedRemaining | Insulet Corporation | In force | High confidence | ||
| US 12,296,139 | Infusion Pump Systems and Methods In force · High confidence | Insulet Corporation | In force | High confidence | ||
| US 7,959,598 | Infusion Pump Systems and Methods In force · High confidence | Insulet Corporation | In force | High confidence | ||
| US 9,078,963 | Infusion Pump Systems and Methods In force · High confidence | Insulet Corporation | In force | High confidence | ||
| US 9,968,729 | Infusion Pump Systems and Methods In force · High confidence | Insulet Corporation | In force | High confidence | ||
| US 10,737,015 | Infusion Pump Systems and Methods In force · High confidence | Insulet Corporation | In force | High confidence | ||
| US 11,865,299 | Infusion Pump Systems and Methods In force · High confidence | Insulet Corporation | In force | High confidence |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.